Onreltea (Brimonidine) Gel In Pediatric Patients With Capillary Malformations
NCT02764411
·
clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
6
Enrollment
OTHER
Sponsor class
Stopped
Poor enrollment, lack of feasibility
Conditions
Capillary Malformations
Interventions
DRUG:
Brimonidine 0.33% gel
Sponsor
The Hospital for Sick Children
Collaborators
[object Object]